home / stock / asp:cc / asp:cc quote
Last: | $3 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0 |
High: | $0 |
Low: | $0 |
Volume: | 36 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3 | $0 | $0 | $0 | $0 | 36 | 08-02-2022 |
$4.71 | $4.91 | $4.71 | $4.91 | $4.71 | 976 | 05-06-2022 |
$4.99 | $5.34 | $4.99 | $5.34 | $4.99 | 1,122 | 05-05-2022 |
$5.11 | $5.1 | $5.11 | $5.56 | $5.02 | 1,667 | 05-04-2022 |
$5.51 | $5.64 | $5.51 | $5.64 | $5.49 | 1,989 | 05-03-2022 |
$5.8 | $4.88 | $5.8 | $6.19 | $4.88 | 12,449 | 05-02-2022 |
$5.12 | $4.99 | $5.12 | $5.125 | $2.86 | 111,211 | 04-29-2022 |
$0.03 | $0.025 | $0.03 | $0.035 | $0.025 | 315,857 | 04-28-2022 |
$0.03 | $0.035 | $0.03 | $0.035 | $0.025 | 1,132,778 | 04-27-2022 |
$0.03 | $0.03 | $0.03 | $0.035 | $0.03 | 197,034 | 04-26-2022 |
$0.035 | $0.04 | $0.035 | $0.04 | $0.03 | 236,399 | 04-25-2022 |
$0.035 | $0.04 | $0.035 | $0.04 | $0.035 | 299,742 | 04-22-2022 |
$0.04 | $0.035 | $0.04 | $0.04 | $0.035 | 167,862 | 04-21-2022 |
$0.04 | $0.035 | $0.04 | $0.04 | $0.035 | 321,299 | 04-20-2022 |
$0.04 | $0.045 | $0.04 | $0.045 | $0.035 | 320,770 | 04-19-2022 |
$0.045 | $0.04 | $0.045 | $0.045 | $0.04 | 125,916 | 04-18-2022 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.04 | 140,405 | 04-15-2022 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.04 | 138,535 | 04-14-2022 |
$0.045 | $0.04 | $0.045 | $0.045 | $0.04 | 68,068 | 04-13-2022 |
$0.045 | $0.04 | $0.045 | $0.045 | $0.04 | 132,335 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Acerus Pharmaceuticals Corporation Company Name:
ASP:CC Stock Symbol:
TSXC Market:
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) and its subsidiaries were granted creditor protection pursuant to an order (the “ Initial Order ”) g...
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “ Acerus ”) were granted protection pursuant to an order (the “ Initial Order ”) issued under the Companies ...
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA,...